Message posted on 15/09/2018

Call for papers - "Responsible innovation in the emerging synthetic biology industry" UK Synthetic Biology Conference, Bristol, 19-20 November 2018

Dear all,

Call for papers for a panel on "Responsible innovation in the emerging
synthetic biology industry". This panel is part of a series of RRI events
that will be held alongside the UK Synthetic Biology conference in Bristol,
19-20 November (organised by BrisSynBio).



Responsible innovation in the emerging synthetic biology industry: challenges,
possibilities, implications

Organizers: Achim Rosemann, Sally Atkinson and Susan Molyneux-Hodgson
(University of Exeter).



RRI frameworks encourage broad, early-stage public engagement and continuous
collaboration between societal actors during the whole of the research and
innovation process. While the origins of RRI lie primarily in academia and the
publicly funded research sector, in recent years the concept has started to
play an increasingly important role in industry innovation. However, as
various commentators have pointed out, there are significant tensions between
public sector RRI and the characteristics and practices of industry innovation
(Dreyer et al. 2017; Lubberink et al. 2017; Stahl 2018).

This panel seeks to explore the challenges, possibilities and implications of
the adoption of RRI ideas, concepts and tools in emerging synthetic biology
industries. Corporations are expected to play a leading role in the
commercialization of synthetic biology over the next years, but how feasible
are existing RRI concepts for industrial biotechnology companies that use
synthetic biology techniques? To what extent and how do (or will) companies
engage with RRI? And how do the meanings, practices and aims of RRI change in
the context of industrial commercialization?

More specifically, the panel aims to generate insights into:

the emerging concepts, discourses and meanings of RRI in the context of
the "industrialization" of synthetic biology
the ways in which RRI ideas are translated into actual practices in
biotech corporations
the hurdles and challenges for the adoption and implementation of RRI
ideas in industrial biotechnology innovation
the tensions between public sector RRI and the characteristics and
requirements of industry innovation
* the (financial, organizational, discursive, etc) implications of the
adoption of RRI ideas in industrial biotechnology, and the ways in which the
adoption of RRI in corporations changes actual innovation and
commercialisation practices
Process and Deadline:

If you would like to participate in this panel, please send your abstract to:
a.rosemann@exeter.ac.uk by 18 September 2018.
Abstracts should be 250 words.

Many thanks,
Sally
Sally Atkinson
Research Associate (Anthropology)
University of Exeter
Telephone: 01392 72 5133
www.exeter.ac.uk
Byrne House, St German's Road , Exeter, Devon, EX4 4PJ
[http://www.exeter.ac.uk/codebox/email-sig/staff-sig.gif]
This email and any attachment may contain information that is confidential,
privileged, or subject to copyright, and which may be exempt from disclosure
under applicable legislation. It is intended for the addressee only. If you
received this message in error, please let me know and delete the email and
any attachments immediately. The University will not accept responsibility for
the accuracy/completeness of this email and its attachments.
___
EASST's Eurograd mailing list
Eurograd (at) lists.easst.net
Unsubscribe or edit subscription options: http://lists.easst.net/listinfo.cgi/eurograd-easst.net

Meet us via https://twitter.com/STSeasst

Report abuses of this list to Eurograd-owner@lists.easst.net

view as plain text

EASST-Eurograd RSS

mailing list
30 recent messages